XML 39 R23.htm IDEA: XBRL DOCUMENT v3.20.4
STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2020
Stockholders' Equity Note [Abstract]  
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY
Share Repurchase Program
In November 2018, the Company announced that the Board of Directors approved the repurchase of an additional $100 million in shares of common stock over a three-year period. This authorization was an increase to the previous $100 million repurchase programs approved in February 2017 and February 2016. The repurchase program is set to expire on February 28, 2022. Stock repurchases under this program may be made in the open market or in private transactions at times and in amounts determined by the Company. As of December 31, 2020, $51.4 million remained available under the program.
Common and Preferred Stock
The Board of Directors has the authority to issue common and unclassed preferred stock of up to 200 million shares and 25 million shares, respectively, with par value of $0.01 per share, as well as to fix dividends, voting and conversion rights, redemption provisions, liquidation preferences, and other rights and restrictions.
Accumulated Other Comprehensive (Loss) Income
Changes in AOCI by component, net of tax, for the years ended December 31, 2020, 2019, and 2018 are summarized as follows (in thousands):
Foreign Currency Translation
and Other		Derivative InstrumentsTotal
Balances at December 31, 2017$(2,385)$— $(2,385)
Net unrealized gains (losses) arising during the period(a)
(193)(660)(853)
Less: Net realized gains (losses) reclassified to net income(b)
— 105 105 
Net change during the period(193)(765)(958)
Balances at December 31, 2018(2,578)(765)(3,343)
Net unrealized gains (losses) arising during the period(c)
712 (3,059)(2,347)
Less: Net realized gains (losses) reclassified to net income(d)
— (1,712)(1,712)
Net change during the period712 (1,347)(635)
Balances at December 31, 2019(1,866)(2,112)(3,978)
Net unrealized gains (losses) arising during the period(e)
(316)6,111 5,795 
Less: Net realized gains (losses) reclassified to net loss(f)
— (5,816)(5,816)
Net change during the period(316)11,927 11,611 
Balances at December 31, 2020$(2,182)$9,815 $7,633 
—————————
(a) Derivative instruments net of $230 thousand of tax benefit for the year ended December 31, 2018.
(b) Derivative instruments net of $37 thousand of tax expense for the year ended December 31, 2018.
(c) Derivative instruments net of $1,031 thousand of tax benefit for the year ended December 31, 2019.
(d) Derivative instruments net of $585 thousand of tax benefit for the year ended December 31, 2019.
(e) Derivative instruments net of $2,058 thousand of tax expense for the year ended December 31, 2020.
(f) Derivative instruments net of $1,962 thousand of tax benefit for the year ended December 31, 2020.